TIDES USA 2026 Post Event eBook

Experts gathered at TIDES USA 2026 in Boston to explore cutting-edge developments in oligonucleotide therapeutics, from personalized CRISPR therapies to novel mRNA-LNP platforms.

This eBook captures keynote insights on breakthrough treatments including in vivo genome editing for ultra-rare diseases, CMC challenges in bringing mRNA drugs to market, and Eli Lilly's promising triagonist retatrutide for diabetes and obesity.

Download now to discover how these innovations are shaping the future of precision medicine and therapeutic development.